Skip to content

Insider · CIK 0001251553

David P Southwell

director

Files at PTCT (PTC THERAPEUTICS, INC.), RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Sep 11, 2025, latest Sep 11, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $700k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PTCT: PTC THERAPEUTICS, INC.

PTCTOct 9, 2026 · close 64.70

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
46Moderate
PTCTsell 5
PTC THERAPEUTICS, INC.
$700k
12,000 shares
-42%+81% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 9, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Common Stock
+12,000$30.86$370k28,850Sep 11, 2025
Sep 9, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-12,000$58.34$700k16,850Sep 11, 2025
Sep 9, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Stock Option (Right to Buy)derivative
-12,000$0.00$00Sep 11, 2025
Jun 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+30,000$0.00$031,660Jul 18, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David P Southwell: insider trades and track record | InsiderTell